Stammdaten
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Unternehmen & Branche
| Name | ENDONOVO THERAPEUTICS, INC. |
|---|---|
| Ticker | ENDV |
| CIK | 0001528172 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 15.938 USD |
| Beta | -8,55 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2023-09-30 | 10-Q | 1,520 | -766,170 | 0.00 | 815,764 | -22,960,131 |
| 2023-06-30 | 10-Q | 45,200 | 2,063,660 | -0.01 | 1,014,821 | -22,411,889 |
| 2023-03-31 | 10-Q | 87,540 | 7,230,502 | 0.00 | 1,198,888 | -24,368,908 |
| 2022-12-31 | 10-K | 135,355 | -18,474,835 | 1,281,266 | -32,180,319 | |
| 2022-09-30 | 10-Q | 10,960 | -603,360 | 0.00 | 1,451,255 | -19,605,879 |
| 2022-06-30 | 10-Q | 650 | -2,526,131 | -0.02 | 1,594,845 | -19,160,134 |
| 2022-03-31 | 10-Q | 2,282 | -2,413,209 | -0.03 | 1,815,055 | -18,036,836 |
| 2021-12-31 | 10-K | 73,105 | -3,104,894 | 2,007,211 | -15,774,324 | |
| 2021-09-30 | 10-Q | 7,790 | -1,523,674 | -0.02 | 2,136,633 | -18,218,396 |
| 2021-06-30 | 10-Q | 30,284 | -1,296,669 | -0.02 | 2,274,492 | -16,984,023 |
| 2021-03-31 | 10-Q | 34,715 | -2,680,881 | -0.06 | 2,521,713 | -15,973,116 |
| 2020-12-31 | 10-K | 165,796 | -395,584 | 2,607,035 | -14,373,786 | |
| 2020-09-30 | 10-Q | 39,980 | -1,069,041 | -0.07 | 2,732,104 | -12,762,282 |
| 2020-06-30 | 10-Q | 44,631 | -1,634,651 | -0.17 | 2,895,667 | -12,182,520 |
| 2020-03-31 | 10-Q | 69,685 | 4,338,418 | -0.14 | 3,066,661 | -11,141,852 |
| 2011-12-31 | 10-K | 45,544 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.